đđŽđēđļđšđšđ˛ đĄ. đđŧđđđŧđģ (đ§đ§đĻ đđąđđ°đŽđđļđŧđģ đđĩđŽđļđŋ) đŽđģđą đ°đŧ-đĩđŧđđ đĻđđ˛đŗđŽđģ đ. đ§đđšđšđļđđ (đđąđļđđŧđŋ-đļđģ-đđĩđļđ˛đŗ, đđŗđĸđ¯đ´đąđđĸđ¯đĩđĸđĩđĒđ°đ¯ đđŧđđŋđģđŽđšđ) đ´đąđĻđĸđŦ đ¸đĒđĩđŠ đđŋđŽđąđšđ˛đ đ. đđŽđŋđąđļđģđ˛đŋ đŽđ¯đŧđđĩ đĩđļđ đĩđĻđĸđŽâđ´ đŋđ˛đ°đ˛đģđđšđē đŊđđ¯đšđļđđĩđ˛đą đēđŽđģđđ´đ°đŋđļđŊđ đļđģ đđŗđĸđ¯đ´đąđđĸđ¯đĩđĸđĩđĒđ°đ¯: âđđšđŧđ¯đŽđš đđēđēđđģđ˛ đđļđŧđēđŽđŋđ¸đ˛đŋđ đŽđģđą đđŧđģđŧđŋ đĻđ˛đŋđŧđđđŽđđđ đđŽđģ đŖđŋđ˛đąđļđ°đ đđđđŧđēđ˛đ´đŽđšđŧđđļđŋđđ đđģđŗđ˛đ°đđļđŧđģ đĒđļđđĩđļđģ đĻđ˛đŋđŧđŊđŧđđļđđļđđ˛ đđđģđ´ đ§đŋđŽđģđđŊđšđŽđģđ đĨđ˛đ°đļđŊđļđ˛đģđđ.â
đĨđ˛đŽđą đđĩđ˛ đŽđŋđđļđ°đšđ˛:
https://journals.lww.com/transplantjoâĻ
đđ˛đŽđŋđģđļđģđ´ đĸđ¯đˇđ˛đ°đđļđđ˛đ
1. Discuss the role of immune biomarkers in predicting CMV and other infections in lung transplant recipients.
2. Explore advantages and limitations of absolute lymphocyte count (ALC) as a predictor.
3. Review data from Gardiner et al. evaluating ALC and mitogen values as predictors of CMV in R+ lung transplant recipients.
4. Highlight recent TTS CMV guidelines relevant to this topic.
â
đđŧđšđšđŧđ & đđ˛đŽđŋđģ đ đŧđŋđ˛
âĸ đ§đ§đĻ: https://tts.org
âĸ đ§đŋđŽđģđđŊđšđŽđģđđŽđđļđŧđģ đđŧđđŋđģđŽđšđ: https://transplantjournal.com
This podcast is for educational purposes and is not a substitute for professional medical advice.
